NO972554D0 - Kryssbundete mikropartikler og anvendelse av samme som terapautiske bærere - Google Patents

Kryssbundete mikropartikler og anvendelse av samme som terapautiske bærere

Info

Publication number
NO972554D0
NO972554D0 NO972554A NO972554A NO972554D0 NO 972554 D0 NO972554 D0 NO 972554D0 NO 972554 A NO972554 A NO 972554A NO 972554 A NO972554 A NO 972554A NO 972554 D0 NO972554 D0 NO 972554D0
Authority
NO
Norway
Prior art keywords
cross
microparticles
same
linked
therapeutic carriers
Prior art date
Application number
NO972554A
Other languages
English (en)
Norwegian (no)
Other versions
NO972554L (no
Inventor
Andrew Derek Sutton
Richard Alan Johnsen
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of NO972554L publication Critical patent/NO972554L/no
Publication of NO972554D0 publication Critical patent/NO972554D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO972554A 1994-12-16 1997-06-05 Kryssbundete mikropartikler og anvendelse av samme som terapautiske bærere NO972554D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94309417 1994-12-16
PCT/GB1995/002925 WO1996018388A2 (en) 1994-12-16 1995-12-14 Cross-linked microparticles and their use as therapeutic vehicles

Publications (2)

Publication Number Publication Date
NO972554L NO972554L (no) 1997-06-05
NO972554D0 true NO972554D0 (no) 1997-06-05

Family

ID=8217949

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972554A NO972554D0 (no) 1994-12-16 1997-06-05 Kryssbundete mikropartikler og anvendelse av samme som terapautiske bærere

Country Status (19)

Country Link
EP (1) EP0796090B1 (da)
JP (1) JP4350165B2 (da)
CN (1) CN1175208A (da)
AT (1) ATE234080T1 (da)
AU (1) AU692019B2 (da)
BR (1) BR9510462A (da)
CA (1) CA2207077C (da)
CZ (1) CZ183797A3 (da)
DE (1) DE69529917T2 (da)
DK (1) DK0796090T3 (da)
ES (1) ES2191721T3 (da)
FI (1) FI972546A (da)
HU (1) HUT77369A (da)
NO (1) NO972554D0 (da)
NZ (1) NZ297072A (da)
PL (1) PL321018A1 (da)
PT (1) PT796090E (da)
WO (1) WO1996018388A2 (da)
ZA (1) ZA9510702B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5955108A (en) * 1994-12-16 1999-09-21 Quadrant Healthcare (Uk) Limited Cross-linked microparticles and their use as therapeutic vehicles
EP0914096B1 (en) * 1996-05-17 2003-08-13 Elan Drug Delivery Limited Microparticles and their use in wound therapy
GB9610830D0 (en) 1996-05-23 1996-07-31 Andaris Ltd Use of hollow microcapsules
GB9615435D0 (en) * 1996-07-23 1996-09-04 Andaris Ltd Spray-dried product and its therapeutic use
GB9621825D0 (en) * 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
WO1998017318A1 (en) * 1996-10-19 1998-04-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules in diagnosis and therapy
EP1028752B1 (en) * 1996-10-21 2004-12-15 Quadrant Drug Delivery Limited Platelet substitutes and conjugation methods suitable for their preparation
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
EP0964676A1 (en) * 1997-01-30 1999-12-22 Quadrant Healthcare (UK) Limited Microparticles and their use in cancer treatment
AU741528B2 (en) 1997-06-05 2001-12-06 Hemosphere, Inc. Fibrinogen-coated microspheres
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9724143D0 (en) * 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
CA2468958C (en) 2001-12-19 2012-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
CA2750725C (en) * 2004-01-07 2014-10-21 Seikagaku Corporation Spacer derivative for hyaluronic acid and non-steroidal anti-inflammatory drug residues
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US7914999B2 (en) * 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
EP2216054A1 (en) 2009-02-06 2010-08-11 ProFibrix BV Biodegradable extravascular support
GB0909136D0 (en) 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
GB0909131D0 (en) 2009-05-28 2009-07-01 Quadrant Drug Delivery Ltd Dry powder fibrin sealant
KR20120125465A (ko) 2010-01-08 2012-11-15 프로피브릭스 비.브이. 건조 분말 피브린 실란트
NO20110653A1 (no) 2011-05-02 2012-11-05 Spiro Medical As Respirasjonsovervakning
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494417B1 (en) * 1991-01-10 1996-04-17 Basf Corporation Process for crosslinking gelatin and for incorporation a material therein
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents

Also Published As

Publication number Publication date
EP0796090A2 (en) 1997-09-24
CA2207077C (en) 2007-02-06
PL321018A1 (en) 1997-11-24
WO1996018388A3 (en) 1996-08-29
CN1175208A (zh) 1998-03-04
AU692019B2 (en) 1998-05-28
MX9704503A (es) 1997-10-31
DK0796090T3 (da) 2003-06-23
ATE234080T1 (de) 2003-03-15
ZA9510702B (en) 1996-12-17
HUT77369A (hu) 1998-03-30
FI972546A0 (fi) 1997-06-16
FI972546A (fi) 1997-07-04
NO972554L (no) 1997-06-05
ES2191721T3 (es) 2003-09-16
EP0796090B1 (en) 2003-03-12
WO1996018388A2 (en) 1996-06-20
DE69529917D1 (de) 2003-04-17
DE69529917T2 (de) 2003-12-11
NZ297072A (en) 1999-03-29
AU4184996A (en) 1996-07-03
PT796090E (pt) 2003-07-31
JPH10510527A (ja) 1998-10-13
JP4350165B2 (ja) 2009-10-21
BR9510462A (pt) 1998-12-15
CZ183797A3 (en) 1997-11-12
CA2207077A1 (en) 1996-06-20

Similar Documents

Publication Publication Date Title
NO972554D0 (no) Kryssbundete mikropartikler og anvendelse av samme som terapautiske bærere
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
FI935306A0 (fi) Anvaendning av renade, ytmodifierande aemnen foer att hindra aggregation av partiklar under sterilisation
NO934315D0 (no) Farmas!ytisk b{rer
MY120109A (en) Disposable body fluid absorbent garment
NO972814L (no) Forlenget-frigjöring granulære preparater og fremgangsmåte for fremstilling derav
ATE386507T1 (de) Mikropartikel
EP0928318A4 (da)
FI922905A (fi) Framstaellning och anvaendning av imidazolfoereningar
IL122972A0 (en) Photochemically cross-linked polysaccharide derivatives their preparation and use
Paul et al. Modified hydroxyapatite microspheres as immunoadsorbent for plasma perfusion: preliminary study
SE9403905D0 (sv) New formulations
CA2464889A1 (en) Cytokine-inducing material and cytokine-inducing instrument
IT1242318B (it) Procedimento di regolazione antibloccaggio e sistema antibloccaggio per la esecuzione del procedimento, in particolare per veicoli da altavelocita'.
Panikkar et al. Modified Polyacrylamide Microspheres as Immunosorbent: Trivandrum-695012. India.
Lou et al. In-vivo and in-vitro targeting of a murine sarcoma by gelatin microparticles loaded with a glycan (PS1)
RU99106170A (ru) Способ профилактики и лечения гиперэндотоксинемии
WO2001028573A3 (en) Monocyte conditioned medium for cancer treatment
SHINOHARA Dress Situations after the Meiji Restoration
Richner et al. In vitro adsorption of colon cancer sera over staphylococcus protein a: lymphocyte stimulation by leakage of adsorbance
SU1369055A1 (ru) Биоспецифические адсорбенты липопротеидов и холестерина
RU97111885A (ru) Сшитые микрочастицы и их применение в качестве терапевтических носителей
RU97102742A (ru) Способ иммобилизации бифидобактерий на биогенном носителе

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application